/ CORRECTION - Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM)
Meets Primary Endpoint With Statistical Significance (p < 0.001) in
CORD I Pivotal Phase III Study for Dupuytren's Contracture
/ CORRECTION - Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM)
Meets Primary Endpoint With Statistical Significance (p < 0.001) in
CORD I Pivotal Phase III Study for Dupuytren's Contracture<img src="http://feeds.foxbusiness.com/~r/foxbusiness/latest/~4/304105815" height="1" width="1"/><img src="http://feeds.foxnews.com/~r/foxnews/business/~4/304107092" height="1" width="1"/>
http://feeds.foxnews.com/~r/foxnews/business/~3/304107092/